CHOC’s multidisciplinary team provides integrative molecular diagnosis and customized treatment plans for children with brain and spine tumors.
CHOC brings leading-edge initiatives to pediatric brain tumor treatment through a collaboration between neurology, neurosurgery and oncology.
CHOC neuro-oncologist initiated a clinical trial to test a vaccine for DIPG, a rare and devastating cancer.
CHOC oncologists developed an app to promote inclusion and support pediatric cancer survivors facing mental health challenges.
CHOC helps develop innovative treatment protocols for PTCL and NK/T-cell lymphoma, which are now available for patients.
When the pandemic hit, CHOC’s psychosocial programs for adolescents and young adults with cancer went virtual but brought new opportunities.